Searched for
GLENMARK SHARE PRICE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...02 Apr, 2026, 12.13 PM IST
- Two Trades for Today: A pharma major for a 6% upmove, a mid-cap healthcare stock for a gain of about 5%Our technical analysts identify select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.29 Mar, 2026, 06.56 PM IST
- Stock Radar: Glenmark Pharma breaks out from a range to hit fresh record high in March 2026; what should investors do?Glenmark Pharma Ltd has broken out of a 7-month consolidation on weekly charts, reaching fresh record highs. Experts suggest short-term tra...18 Mar, 2026, 05.00 AM IST
- Two Trades for Today: Two pharma stocks, one a mid-cap for a 6.7% gain, the other a large-cap for an upmove of almost 6%Our technical analysts identify select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.07 Jan, 2026, 08.11 PM IST
- Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in USGlenmark share price: The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark Pharm...03 Mar, 2025, 09.25 AM IST
- Two Trades for Today: A large-cap pharma stock for almost 5% gain; a mid-cap IT solutions provider for 6% upmoveSelect stocks gain momentum even in volatile markets.08 Jan, 2025, 05.00 AM IST
- Glenmark Pharma to sell 7.84% stake in Glenmark Life via OFSThe stake sale will be done through the stock exchanges via an offer for sale (OFS). The decision was made at a meeting held today, and the...10 Jul, 2024, 04.14 PM IST
- Glenmark Pharma shares fall over 6% on subsidiary stake sale to NirmaGlenmark Pharmaceuticals has entered into a definitive agreement with Nirma to divest a 75% stake in Glenmark Life Sciences for Rs 5,651.5 ...22 Sep, 2023, 11.26 AM IST
- Buy Glenmark Pharma, target price Rs 560: Yes SecuritiesGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a mid-cap company (with a market cap of Rs 14826.53 crore) operating in ph...29 Nov, 2021, 09.37 AM IST
- Interim data from study supports Favipiravir's safety, effectiveness: GlenmarkThe study, commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.09 Jun, 2021, 12.33 AM IST
- Glenmark drops 6% as Q2 net profit declinesThe stock has nearly trebled from its March lows of Rs 168, and is up 39 per cent year-to-date.09 Nov, 2020, 01.20 PM IST
- Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 croreConsolidated revenue stood at Rs 2,344.78 crore for the first quarter compared with Rs 2,322.87 crore in the year-ago period, Glenmark Phar...17 Aug, 2020, 12.29 PM IST
- Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.23 Jun, 2020, 09.33 AM IST
- Buy Glenmark Pharmaceuticals, target Rs 660: Kunal BothraBuy Glenmark Pharmaceuticals Ltd. at a price target of Rs 660.0 and a stoploss at Rs 620 from entry point.06 May, 2019, 09.06 AM IST
- Sell Glenmark Pharma, target Rs 485: Dr CK NarayanSell Glenmark Pharmaceuticals Ltd. at a price target of Rs 485 and a stop loss at Rs 510 from entry point.21 May, 2018, 09.09 AM IST
- Buy Glenmark Pharmaceuticals, target Rs 610: Manas JaiswalBuy Glenmark Pharmaceuticals Ltd. at a price target of Rs 610.0 and a stop loss at Rs 567 from the entry point.16 Apr, 2018, 09.36 AM IST
Load More
